K. West

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells

B. Champion, K. Fisher, S. Hemmi, 2018, Journal of Immunotherapy for Cancer.

T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice

Daniel E. Zak, D. Zak, B. Champion, 2022, Oncoimmunology.

Abstract 5013: NG-641: An oncolytic T-SIGn virus targeting cancer-associated fibroblasts in the stromal microenvironment of human carcinomas

B. Champion, Stefania Fedele, G. D. Genova, 2019, Immunology.